Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074

Summary

To evaluate the safety and tolerability of ascending oral doses of CHF 5074 administered once per day for up to 12 weeks to patients with mild cognitive impairment.

Timeline

Start

2011-03

Primary completion

2012-04

Completion

2012-04

Drugs

Indications